FRESENIUS MEDICAL CARE AG (1FME.MI) Stock Fundamental Analysis
Europe - Euronext Milan - BIT:1FME - DE0005785802 - Common Stock
40.4 EUR
-1.49 (-3.56%)
1FME gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 30 industry peers in the Health Care Providers & Services industry. Both the profitability and the financial health of 1FME get a neutral evaluation. Nothing too spectacular is happening here. 1FME is not valued too expensively and it also shows a decent growth rate. Finally 1FME also has an excellent dividend rating. With these ratings, 1FME could be worth investigating further for dividend investing!.
1. Profitability
1.1 Basic Checks
- In the past year 1FME was profitable.
- In the past year 1FME had a positive cash flow from operations.
- In the past 5 years 1FME has always been profitable.
- In the past 5 years 1FME always reported a positive cash flow from operatings.
1.2 Ratios
- With a Return On Assets value of 2.33%, 1FME perfoms like the industry average, outperforming 48.48% of the companies in the same industry.
- The Return On Equity of 1FME (5.55%) is comparable to the rest of the industry.
- 1FME has a Return On Invested Capital of 3.95%. This is comparable to the rest of the industry: 1FME outperforms 45.45% of its industry peers.
- 1FME had an Average Return On Invested Capital over the past 3 years of 3.14%. This is below the industry average of 6.46%.
- The 3 year average ROIC (3.14%) for 1FME is below the current ROIC(3.95%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.33% | ||
| ROE | 5.55% | ||
| ROIC | 3.95% |
ROA(3y)1.65%
ROA(5y)2.29%
ROE(3y)4.06%
ROE(5y)6.04%
ROIC(3y)3.14%
ROIC(5y)4%
1.3 Margins
- Looking at the Profit Margin, with a value of 3.66%, 1FME is in the better half of the industry, outperforming 63.64% of the companies in the same industry.
- 1FME's Profit Margin has declined in the last couple of years.
- 1FME has a better Operating Margin (7.19%) than 60.61% of its industry peers.
- In the last couple of years the Operating Margin of 1FME has declined.
- The Gross Margin of 1FME (25.00%) is comparable to the rest of the industry.
- 1FME's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 7.19% | ||
| PM (TTM) | 3.66% | ||
| GM | 25% |
OM growth 3Y-13.44%
OM growth 5Y-12.95%
PM growth 3Y-20.33%
PM growth 5Y-16.53%
GM growth 3Y-3.16%
GM growth 5Y-4.44%
2. Health
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), 1FME is destroying value.
- Compared to 1 year ago, 1FME has about the same amount of shares outstanding.
- The number of shares outstanding for 1FME has been reduced compared to 5 years ago.
- 1FME has a better debt/assets ratio than last year.
2.2 Solvency
- 1FME has an Altman-Z score of 2.20. This is not the best score and indicates that 1FME is in the grey zone with still only limited risk for bankruptcy at the moment.
- With a Altman-Z score value of 2.20, 1FME perfoms like the industry average, outperforming 51.52% of the companies in the same industry.
- The Debt to FCF ratio of 1FME is 5.97, which is a neutral value as it means it would take 1FME, 5.97 years of fcf income to pay off all of its debts.
- The Debt to FCF ratio of 1FME (5.97) is better than 72.73% of its industry peers.
- A Debt/Equity ratio of 0.73 indicates that 1FME is somewhat dependend on debt financing.
- The Debt to Equity ratio of 1FME (0.73) is better than 69.70% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.73 | ||
| Debt/FCF | 5.97 | ||
| Altman-Z | 2.2 |
ROIC/WACC0.7
WACC5.67%
2.3 Liquidity
- A Current Ratio of 1.36 indicates that 1FME should not have too much problems paying its short term obligations.
- With a decent Current ratio value of 1.36, 1FME is doing good in the industry, outperforming 69.70% of the companies in the same industry.
- 1FME has a Quick Ratio of 1.36. This is a bad value and indicates that 1FME is not financially healthy enough and could expect problems in meeting its short term obligations.
- With a decent Quick ratio value of 1.00, 1FME is doing good in the industry, outperforming 63.64% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.36 | ||
| Quick Ratio | 1 |
3. Growth
3.1 Past
- 1FME shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 16.77%, which is quite good.
- The Earnings Per Share has been decreasing by -6.43% on average over the past years.
- The Revenue has been growing slightly by 2.10% in the past year.
- The Revenue has been growing slightly by 2.04% on average over the past years.
EPS 1Y (TTM)16.77%
EPS 3Y-1.97%
EPS 5Y-6.43%
EPS Q2Q%34.15%
Revenue 1Y (TTM)2.1%
Revenue growth 3Y3.15%
Revenue growth 5Y2.04%
Sales Q2Q%2.63%
3.2 Future
- 1FME is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 13.73% yearly.
- Based on estimates for the next years, 1FME will show a small growth in Revenue. The Revenue will grow by 4.08% on average per year.
EPS Next Y21.73%
EPS Next 2Y12.96%
EPS Next 3Y13.16%
EPS Next 5Y13.73%
Revenue Next Year1.57%
Revenue Next 2Y2.26%
Revenue Next 3Y2.91%
Revenue Next 5Y4.08%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
- 1FME is valuated reasonably with a Price/Earnings ratio of 10.74.
- Based on the Price/Earnings ratio, 1FME is valued cheaper than 87.88% of the companies in the same industry.
- 1FME is valuated cheaply when we compare the Price/Earnings ratio to 27.38, which is the current average of the S&P500 Index.
- 1FME is valuated reasonably with a Price/Forward Earnings ratio of 9.74.
- Based on the Price/Forward Earnings ratio, 1FME is valued cheaper than 90.91% of the companies in the same industry.
- The average S&P500 Price/Forward Earnings ratio is at 24.29. 1FME is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.74 | ||
| Fwd PE | 9.74 |
4.2 Price Multiples
- 1FME's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. 1FME is more expensive than 60.61% of the companies in the same industry.
- Compared to the rest of the industry, the Price/Free Cash Flow ratio of 1FME is on the same level as its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 13.51 | ||
| EV/EBITDA | 10.52 |
4.3 Compensation for Growth
- The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
- A more expensive valuation may be justified as 1FME's earnings are expected to grow with 13.16% in the coming years.
PEG (NY)0.49
PEG (5Y)N/A
EPS Next 2Y12.96%
EPS Next 3Y13.16%
5. Dividend
5.1 Amount
- 1FME has a Yearly Dividend Yield of 3.54%.
- Compared to an average industry Dividend Yield of 1.73, 1FME pays a better dividend. On top of this 1FME pays more dividend than 93.94% of the companies listed in the same industry.
- 1FME's Dividend Yield is rather good when compared to the S&P500 average which is at 1.85.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.54% |
5.2 History
- The dividend of 1FME has a limited annual growth rate of 0.31%.
Dividend Growth(5Y)0.31%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
- 1FME pays out 58.83% of its income as dividend. This is a bit on the high side, but may be sustainable.
- 1FME's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP58.83%
EPS Next 2Y12.96%
EPS Next 3Y13.16%
BIT:1FME (12/15/2025, 7:00:00 PM)
40.4
-1.49 (-3.56%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-04 2025-11-04/bmo
Earnings (Next)02-24 2026-02-24/amc
Inst Owners43.88%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap23.71B
Revenue(TTM)19.64B
Net Income(TTM)718.19M
Analysts57.93
Price Target47.84 (18.42%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.54% |
Yearly Dividend1.19
Dividend Growth(5Y)0.31%
DP58.83%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)14.52%
Min EPS beat(2)14.16%
Max EPS beat(2)14.89%
EPS beat(4)4
Avg EPS beat(4)17.81%
Min EPS beat(4)14.16%
Max EPS beat(4)27.17%
EPS beat(8)7
Avg EPS beat(8)16.37%
EPS beat(12)10
Avg EPS beat(12)13.79%
EPS beat(16)12
Avg EPS beat(16)10.84%
Revenue beat(2)0
Avg Revenue beat(2)-2.52%
Min Revenue beat(2)-3.33%
Max Revenue beat(2)-1.71%
Revenue beat(4)2
Avg Revenue beat(4)0.94%
Min Revenue beat(4)-3.33%
Max Revenue beat(4)6.05%
Revenue beat(8)3
Avg Revenue beat(8)-0.62%
Revenue beat(12)4
Avg Revenue beat(12)-0.64%
Revenue beat(16)6
Avg Revenue beat(16)-0.51%
PT rev (1m)-3.67%
PT rev (3m)-7.99%
EPS NQ rev (1m)-0.91%
EPS NQ rev (3m)-2.96%
EPS NY rev (1m)2.83%
EPS NY rev (3m)6.76%
Revenue NQ rev (1m)0.31%
Revenue NQ rev (3m)0.93%
Revenue NY rev (1m)0.37%
Revenue NY rev (3m)-0.25%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.74 | ||
| Fwd PE | 9.74 | ||
| P/S | 1.21 | ||
| P/FCF | 13.51 | ||
| P/OCF | 9.44 | ||
| P/B | 1.83 | ||
| P/tB | N/A | ||
| EV/EBITDA | 10.52 |
EPS(TTM)3.76
EY9.31%
EPS(NY)4.15
Fwd EY10.26%
FCF(TTM)2.99
FCFY7.4%
OCF(TTM)4.28
OCFY10.59%
SpS33.47
BVpS22.07
TBVpS-3.21
PEG (NY)0.49
PEG (5Y)N/A
Graham Number43.21
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.33% | ||
| ROE | 5.55% | ||
| ROCE | 5.62% | ||
| ROIC | 3.95% | ||
| ROICexc | 4.26% | ||
| ROICexgc | 11.65% | ||
| OM | 7.19% | ||
| PM (TTM) | 3.66% | ||
| GM | 25% | ||
| FCFM | 8.93% |
ROA(3y)1.65%
ROA(5y)2.29%
ROE(3y)4.06%
ROE(5y)6.04%
ROIC(3y)3.14%
ROIC(5y)4%
ROICexc(3y)3.31%
ROICexc(5y)4.22%
ROICexgc(3y)8.52%
ROICexgc(5y)10.56%
ROCE(3y)4.51%
ROCE(5y)5.77%
ROICexgc growth 3Y-7.67%
ROICexgc growth 5Y-10.05%
ROICexc growth 3Y-10.35%
ROICexc growth 5Y-11.48%
OM growth 3Y-13.44%
OM growth 5Y-12.95%
PM growth 3Y-20.33%
PM growth 5Y-16.53%
GM growth 3Y-3.16%
GM growth 5Y-4.44%
F-Score5
Asset Turnover0.64
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.73 | ||
| Debt/FCF | 5.97 | ||
| Debt/EBITDA | 3.12 | ||
| Cap/Depr | 47.15% | ||
| Cap/Sales | 3.85% | ||
| Interest Coverage | 3.87 | ||
| Cash Conversion | 83.24% | ||
| Profit Quality | 244.33% | ||
| Current Ratio | 1.36 | ||
| Quick Ratio | 1 | ||
| Altman-Z | 2.2 |
F-Score5
WACC5.67%
ROIC/WACC0.7
Cap/Depr(3y)41.32%
Cap/Depr(5y)47.87%
Cap/Sales(3y)3.79%
Cap/Sales(5y)4.49%
Profit Quality(3y)300.36%
Profit Quality(5y)267.36%
High Growth Momentum
Growth
EPS 1Y (TTM)16.77%
EPS 3Y-1.97%
EPS 5Y-6.43%
EPS Q2Q%34.15%
EPS Next Y21.73%
EPS Next 2Y12.96%
EPS Next 3Y13.16%
EPS Next 5Y13.73%
Revenue 1Y (TTM)2.1%
Revenue growth 3Y3.15%
Revenue growth 5Y2.04%
Sales Q2Q%2.63%
Revenue Next Year1.57%
Revenue Next 2Y2.26%
Revenue Next 3Y2.91%
Revenue Next 5Y4.08%
EBIT growth 1Y-3.43%
EBIT growth 3Y-10.72%
EBIT growth 5Y-11.17%
EBIT Next Year96.22%
EBIT Next 3Y29.78%
EBIT Next 5Y18.68%
FCF growth 1Y-5.89%
FCF growth 3Y1.25%
FCF growth 5Y3.45%
OCF growth 1Y0.06%
OCF growth 3Y-1.4%
OCF growth 5Y-1.45%
FRESENIUS MEDICAL CARE AG / 1FME.MI FAQ
What is the fundamental rating for 1FME stock?
ChartMill assigns a fundamental rating of 5 / 10 to 1FME.MI.
Can you provide the valuation status for FRESENIUS MEDICAL CARE AG?
ChartMill assigns a valuation rating of 6 / 10 to FRESENIUS MEDICAL CARE AG (1FME.MI). This can be considered as Fairly Valued.
Can you provide the profitability details for FRESENIUS MEDICAL CARE AG?
FRESENIUS MEDICAL CARE AG (1FME.MI) has a profitability rating of 5 / 10.
What are the PE and PB ratios of FRESENIUS MEDICAL CARE AG (1FME.MI) stock?
The Price/Earnings (PE) ratio for FRESENIUS MEDICAL CARE AG (1FME.MI) is 10.74 and the Price/Book (PB) ratio is 1.83.
Can you provide the financial health for 1FME stock?
The financial health rating of FRESENIUS MEDICAL CARE AG (1FME.MI) is 5 / 10.